CNTA
Price
$17.18
Change
-$0.37 (-2.11%)
Updated
Dec 20, 04:59 PM (EDT)
96 days until earnings call
PRQR
Price
$2.64
Change
+$0.05 (+1.93%)
Updated
Dec 20, 04:59 PM (EDT)
67 days until earnings call
Ad is loading...

CNTA vs PRQR

Header iconCNTA vs PRQR Comparison
Open Charts CNTA vs PRQRBanner chart's image
Centessa Pharmaceuticals
Price$17.18
Change-$0.37 (-2.11%)
Volume$12.48K
CapitalizationN/A
ProQR Therapeutics
Price$2.64
Change+$0.05 (+1.93%)
Volume$15.11K
CapitalizationN/A
CNTA vs PRQR Comparison Chart
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. PRQR commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Hold and PRQR is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (CNTA: $17.18 vs. PRQR: $2.65)
Brand notoriety: CNTA and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 138% vs. PRQR: 27%
Market capitalization -- CNTA: $2.27B vs. PRQR: $281.18M
CNTA [@Biotechnology] is valued at $2.27B. PRQR’s [@Biotechnology] market capitalization is $281.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNTA and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 5 bearish.
  • PRQR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CNTA and PRQR are a bad buy in the short-term.

Price Growth

CNTA (@Biotechnology) experienced а +3.68% price change this week, while PRQR (@Biotechnology) price change was -6.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

CNTA is expected to report earnings on Mar 27, 2025.

PRQR is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($2.27B) has a higher market cap than PRQR($281M). CNTA YTD gains are higher at: 115.829 vs. PRQR (34.091). PRQR has higher annual earnings (EBITDA): -18.59M vs. CNTA (-147.19M). CNTA has more cash in the bank: 518M vs. PRQR (89.4M). PRQR has less debt than CNTA: PRQR (17.4M) vs CNTA (84.7M). PRQR has higher revenues than CNTA: PRQR (17.9M) vs CNTA (6.85M).
CNTAPRQRCNTA / PRQR
Capitalization2.27B281M806%
EBITDA-147.19M-18.59M792%
Gain YTD115.82934.091340%
P/E RatioN/AN/A-
Revenue6.85M17.9M38%
Total Cash518M89.4M579%
Total Debt84.7M17.4M487%
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTAPRQR
RSI
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUESX33.140.38
+1.16%
MFS Blended Research Core Equity R2
DALVX20.090.23
+1.16%
Dunham Large Cap Value A
LAFQX18.800.20
+1.08%
Lord Abbett Affiliated R2
DGEFX12.590.12
+0.96%
Destinations Equity Income I
RIOIX8.55N/A
N/A
RBC International Opportunities I

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-2.11%
XENE - CNTA
37%
Loosely correlated
-0.54%
VCYT - CNTA
37%
Loosely correlated
+4.66%
OCUL - CNTA
35%
Loosely correlated
+0.59%
CRNX - CNTA
35%
Loosely correlated
+1.44%
RARE - CNTA
34%
Loosely correlated
+1.73%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
+2.51%
KRRO - PRQR
54%
Loosely correlated
+1.69%
ATNF - PRQR
48%
Loosely correlated
-1.03%
WVE - PRQR
48%
Loosely correlated
+2.39%
ENVB - PRQR
43%
Loosely correlated
+0.18%
LOGC - PRQR
32%
Poorly correlated
+1.51%
More